Denver Solutions, LLC (DBA Leiters Health) is recalling 1,440 vials of Moxifloxacin, a medication used for injections into the eye during surgery. The recall was initiated because vials labeled as containing a 1 mg/mL concentration may actually contain a 5 mg/mL concentration, which is five times the labeled dose. No injuries or incidents have been reported to date, but the higher dosage could cause harm if administered.
The incorrect labeling results in patients receiving a much higher dose of medication than intended, which can cause toxic effects to the sensitive tissues of the eye. Administering 5 mg/mL instead of 1 mg/mL significantly increases the risk of eye toxicity.
Solution for intracameral injection.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.